НовостиBenzingaWedbush Reiterates Outperform on Oruka Therapeutics, Maintains $165 Price Target Wedbush Reiterates Outperform on Oruka Therapeutics, Maintains $165 Price Target Benzinga 2026.09.24 12:40 (GMT+0) Открыть на Benzinga Другие новости